{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:43:20Z","timestamp":1761965000138,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.jpeds.2011.01.017","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T04:33:02Z","timestamp":1298608382000},"page":"291-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Risk Factors for Medication-Induced Diabetes and Type 2 Diabetes"],"prefix":"10.1016","volume":"159","author":[{"given":"Shazhan","family":"Amed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.C.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constadina","family":"Panagiotopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiju R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian L.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa A.","family":"Laubscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dannenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stasia","family":"Hadjiyannakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2011.01.017_bib1","first-page":"400","article-title":"Secondary diabetes in children","volume":"28","author":"Ho","year":"2004","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jpeds.2011.01.017_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/070674370905401104","article-title":"Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications","volume":"54","author":"Panagiotopoulos","year":"2009","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jpeds.2011.01.017_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/088307380201700405","article-title":"Insulin resistance in epileptic girls who gain weight after therapy with valproic acid","volume":"17","author":"Verrotti","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jpeds.2011.01.017_bib4","first-page":"27","article-title":"Overweight and obesity among children and youth","volume":"17","author":"Shields","year":"2006","journal-title":"Health Rep"},{"key":"10.1016\/j.jpeds.2011.01.017_bib5","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.transproceed.2005.07.037","article-title":"High incidence of early posttransplantation diabetes mellitus in an eastern population","volume":"37","author":"Mohsin","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jpeds.2011.01.017_bib6","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.transproceed.2005.02.086","article-title":"Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients","volume":"37","author":"Numakura","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jpeds.2011.01.017_bib7","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1016\/j.transproceed.2005.09.197","article-title":"Posttransplantation diabetes mellitus: prevalence and risk factors","volume":"37","author":"Baltar","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jpeds.2011.01.017_bib8","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.transproceed.2005.08.039","article-title":"Incidence of posttransplantation diabetes mellitus in kidney transplantation: a single-center experience","volume":"37","author":"Roozbeh","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jpeds.2011.01.017_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jpeds.2011.01.017_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ndt\/18.1.164","article-title":"Post-transplant hyperglycaemia: a study of risk factors","volume":"18","author":"Mathew","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpeds.2011.01.017_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","article-title":"Posttransplantation diabetes: a systematic review of the literature","volume":"25","author":"Montori","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2011.01.017_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004670200000","article-title":"Increased incidence in posttransplant diabetes mellitus in children: a case-control analysis","volume":"17","author":"Greenspan","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpeds.2011.01.017_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00007890-200109270-00007","article-title":"Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"72","author":"Al-Uzri","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jpeds.2011.01.017_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0041-1345(98)00290-5","article-title":"Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients","volume":"30","author":"Jain","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jpeds.2011.01.017_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1442-200X.2007.02418.x","article-title":"Diabetes mellitus after stem cell transplantation in a patient with acute lymphoblastic leukemia: possible association with tacrolimus","volume":"49","author":"Niwa","year":"2007","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2011.01.017_bib16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00467-006-0102-x","article-title":"Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment","volume":"21","author":"Dittrich","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpeds.2011.01.017_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pbc.21505","article-title":"Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia","volume":"50","author":"Roberson","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2011.01.017_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1499-2671(10)42006-7","article-title":"prevalence and associated risk factors for secondary in Canadian children followed in pediatric tertiary care centres","volume":"34","author":"Ho","year":"2010","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jpeds.2011.01.017_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2337\/dc09-1013","article-title":"Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study","volume":"33","author":"Amed","year":"2010","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2011.01.017_bib20","first-page":"S7","article-title":"2003 clinical practice guidelines for the prevention and management of diabetes in Canada: definition, classification and diagnosis of diabetes and other dysglycemic categories","volume":"27","year":"2003","journal-title":"Can J Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2011.01.017_bib21","first-page":"S10","article-title":"2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","year":"2008","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jpeds.2011.01.017_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/dc06-1813","article-title":"Rising incidence of type 2 diabetes in children in the UK","volume":"30","author":"Haines","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpeds.2011.01.017_bib23","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/jama.297.24.2716","article-title":"Incidence of diabetes in youth in the United States","volume":"297","author":"Dabelea","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2011.01.017_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00007890-200101270-00015","article-title":"Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression","volume":"71","author":"Paolillo","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jpeds.2011.01.017_bib25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/pbc.20320","article-title":"Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia","volume":"45","author":"Baillargeon","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2011.01.017_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3476(81)80955-9","article-title":"Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone","volume":"99","author":"Pui","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2011.01.017_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/pbc.21980","article-title":"Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia","volume":"52","author":"Lowas","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2011.01.017_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/pbc.21624","article-title":"Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia","volume":"51","author":"Sonabend","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2011.01.017_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.tp.0000259617.21741.95","article-title":"Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients","volume":"83","author":"Burroughs","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jpeds.2011.01.017_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/erc.10.15","article-title":"Type 2 diabetes in children and adolescents","volume":"8","author":"Amed","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347611000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347611000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:53:11Z","timestamp":1758358391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347611000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0022347611000655"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2011.01.017","relation":{},"ISSN":["0022-3476"],"issn-type":[{"type":"print","value":"0022-3476"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Medication-Induced Diabetes and Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2011.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}